Comparative evaluation demonstrates improved generalisability of machine learning over radiomic risk scores in glioblastoma, suggesting robust risk stratification for clinical care.
Accurate patient prognosis is important to provide an effective treatment plan for Glioblastoma (GBM) patients. Radiomics analysis extracts quantitative features from medical images. Such features can be used to build models to support medical decisions for diagnosis, prognosis, and therapeutic response. The progress of radiomics analysis is continuously improving. The aim of this research is to extract standardised radiomic features from MRI scans of GBM patients, perform feature selection, and compare radiomic-based risk score (RRS) and machine learning (ML) approaches for the risk stratification of GBM patients. We have also tested the generalisability of these models which is crucial for clinical implementation. Our work demonstrates that a stratification model based on logistic regression generalised better than the RRS method when applied to new unseen datasets.
No takes yet. Share an insight, caveat, or question.
Duman et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: